Physician profile
Davinder Singh
NPI 1255952081
$795.38
in general payments reported to CMS, 2019-2025
8 companies · $771 in 2025
The $771 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $24.65 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.87 |
| Education | $238.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $482.78 | 2025 | Cardiomems, Ensite |
| Novartis Pharmaceuticals Corporation | $93.07 | 2025 | |
| Shockwave Medical, INC | $82.86 | 2025 | |
| Stryker Corporation | $37.70 | 2025 | Flowtriever |
| Astrazeneca Pharmaceuticals LP | $32.77 | 2025 | Farxiga |
| Boston Scientific Corporation | $25.68 | 2025 | Emblem Mri S-Icd |
| Abiomed | $24.65 | 2024 | Impella |
| Chiesi USA, INC. | $15.87 | 2025 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Davinder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.